Drug Database · Clinicians

Biphasic isophane insulin

Brands (5) Choicesulin, Excel-Insu Mix 30/70, Glysolin 30/70…Show all

Intermediate acting insulin PH FDA category

Rx · Prescription drug6 PH productsVAT-exempt
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Suspension for injection: 100 IU/mL

Registered products in the Philippines

6 products registered with the Food and Drug Administration (FDA) Philippines list Biphasic isophane insulin as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

All registered products6
Philippine FDA-registered products for Biphasic isophane insulin
Package insert
ChoicesulinBiphasic Isophane Insulin (rDNA)
100 IU/mL Suspension for Injection (SC)10 mL Glass Vial with Rubber Stopper and Brown Flip-Off Seal Box of 10's
RxVAT-exempt
Wockhardt LimitedIndia
Medchoice Endocrine Group Inc.Importer: Ambica International Corporation
BRP-034-02
Sep 5, 2027
Excel-Insu Mix 30/70Biphasic Isophane Insulin (rDNA Origin)
100 IU/mL Suspension for Injection (SC)10 mL glass vial with rubber stopper and brown flip-off seal (Box of 1's)
RxVAT-exempt
Wockhardt LimitedIndia
Diafarm Inc.Importer: Ambica International Corporation
BRP-034-03
Sep 5, 2027
Glysolin 30/70Biphasic Isophane Insulin (rDNA Origin)
100 IU/mL Suspension for Injection (S.C.)10 mL glass vial with rubber stopper and brown flip-off seal Box of 1's
RxVAT-exempt
Wockhardt Ltd.India
The Cathay YSS Distributors Co., Inc.Importer: Ambica International Corporation
BRP-034-01
Sep 5, 2027
Lupinsulin-30/70Biphasic Isophane Insulin (rDNA Origin)
100 IU/mL Suspension for Injection (SC)10 mL Glass Vial with Rubber Stopper and Brown Flip-off Seal (Box of 1's)
RxVAT-exempt
Wockhardt LimitedIndia
Multicare Pharmaceuticals Phils. Inc.Importer: Ambica International Corporation
BRP-034-04
Sep 5, 2027
NoneBiphasic Isophane Insulin (rDNA Origin)
100 IU/mL Suspension for Injection (SC)10 mL glass vial with rubber stopper and brown flip-off seal Box of 1's
RxVAT-exempt
Wockhardt LimitedIndia
Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation
BRP-034-05
Sep 5, 2027
Wosulin-30/70Biphasic Isophane Insulin (rDNA Origin)
100 IU/mL Suspension for Injection (SC)10 mL glass vial with rubber stopper and brown flip-off seal Box of 1's
RxVAT-exempt
Wockhardt LimitedIndia
Ambica International Corporation
BRP-034
Sep 5, 2027

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Government price references

PreparationPrice (PHP)UnitType
Insulin, Biphasic Isophane Human 70/30 (recombinant DNA) 70% isophane suspension + 30% soluble insulin in 100 IU/mL, 10 mL Vial₱70.00–₱623.40Reference ₱89.00per vialDPRI procurement range

Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)

These are government procurement and reimbursement references, not retail prices. Sources:

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
  2. DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .